Bioethicist Kelly Ormond in an interview of The Economist on how genetic editing will change humanity
The Economist podcast on science and technology, this week, presenting from a human genome editing summit to explore the applications and ethics of a technology that could transform medicine.
The third international conference on human genome editing in London in March brought together leading scientists in the field. An exciting exchange on the challenges, dangers and opportunities arising from gene editing therapy.
The focus lay on new technologies that are being used and tested in clinical trials and their potential risks for biosafety. Keyword: ethical dilemmas.
In her latest interview in external pageThe Economist, Kelly Ormond, bioethicist at the Institute for Translational Medicine at ETH Zurich, talks about the ethical issues involved:
Who should be able to use the technologies?
How should these procedures be allowed to be used and how can misuse be prevented.
You can listen to the interview external pagehere